H E Seaman
Overview
Explore the profile of H E Seaman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
336
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cooper J, Moss S, Smith S, Seaman H, Taylor-Phillips S, Parsons N, et al.
Colorectal Dis
. 2016 May;
18(7):650-3.
PMID: 27135192
Worldwide, the guaiac faecal occult blood test (gFOBT) is being replaced with the more accurate faecal immunochemical test (FIT) for colorectal cancer (CRC) screening. From January 2016, the National Screening...
2.
Ballard K, Seaman H, de Vries C, Wright J
BJOG
. 2008 Aug;
115(11):1382-91.
PMID: 18715240
Objective: To determine the value of patient-reported symptoms in diagnosing endometriosis. Design: A national case-control study. Setting: Data from the UK General Practice Research Database for years 1992-2001. Sample: A...
3.
Seaman H, Ballard K, Wright J, de Vries C
BJOG
. 2008 Aug;
115(11):1392-6.
PMID: 18715239
Objective: To investigate whether the increased chances of having a diagnosis of irritable bowel syndrome (IBS) and pelvic inflammatory disease (PID) in women with endometriosis is due to misdiagnosis or...
4.
Mulnier H, Seaman H, Raleigh V, Soedamah-Muthu S, Colhoun H, Lawrenson R, et al.
Diabetologia
. 2008 Jun;
51(9):1639-45.
PMID: 18581091
Aims/hypothesis: Our primary aim was to establish reliable and generalisable estimates of the risk of myocardial infarction (MI) for men and women with type 2 diabetes in the UK compared...
5.
Mulnier H, Seaman H, Raleigh V, Soedamah-Muthu S, Colhoun H, Lawrenson R, et al.
Diabetologia
. 2006 Oct;
49(12):2859-65.
PMID: 17072582
Aims/hypothesis: Risk estimates for stroke in patients with diabetes vary. We sought to obtain reliable risk estimates for stroke and the association with diabetes, comorbidity and lifestyle in a large...
6.
Mulnier H, Seaman H, Raleigh V, Soedamah-Muthu S, Colhoun H, Lawrenson R
Diabet Med
. 2006 May;
23(5):516-21.
PMID: 16681560
Aims: Under-reporting of diabetes on death certificates contributes to the unreliable estimates of mortality as a result of diabetes. The influence of obesity on mortality in Type 2 diabetes is...
7.
Seaman H, de Vries C, Farmer R
Pharmacoepidemiol Drug Saf
. 2004 Jul;
13(7):427-36.
PMID: 15269926
Purpose: To derive risk estimates for venous thromboembolism (VTE) in women prescribed cyproterone acetate combined with ethinyloestradiol (CPA/EE), a drug licensed in the UK for the treatment of women with...
8.
Seaman H, de Vries C, Farmer R
Pharmacoepidemiol Drug Saf
. 2003 Oct;
12(7):541-50.
PMID: 14558177
Purpose: To explore the risk of liver disorders associated with cyproterone acetate combined with ethinyloestradiol (CPA/EE). CPA/EE is licensed in the UK for the treatment of women with acne and...
9.
Seaman H, de Vries C, Farmer R
Hum Reprod
. 2003 Mar;
18(3):522-6.
PMID: 12615818
Background: Cyproterone acetate combined with ethinyl estradiol (CPA/EE) is licensed in the UK for the treatment of women with acne and hirsutism and is also a treatment option for polycystic...
10.
Seaman H, de Vries C, Farmer R
Hum Reprod
. 2003 Mar;
18(3):515-21.
PMID: 12615817
Background: Cyproterone acetate combined with ethinyl estradiol (CPA/EE) provides a treatment option for women with acne, hirsutism or polycystic ovary syndrome (PCOS). CPA/EE may be prescribed as an oral contraceptive...